Cited by 211Epilepsy research and treatmentNeuroscience and Neuropharmacology ResearchNeural dynamics and brain function

Perineuronal nets decrease membrane capacitance of peritumoral fast spiking interneurons in a model of epilepsy

Open access
Tewari, Bhanu P., Chaunsali, Lata, Campbell, Susan L., Patel, Dipan C., Goode, Adam E., Sontheimer, Harald·2018·Nature Communications

Abstract

Brain tumor patients commonly present with epileptic seizures. We show that tumor-associated seizures are the consequence of impaired GABAergic inhibition due to an overall loss of peritumoral fast spiking interneurons (FSNs) concomitant with a significantly reduced firing rate of those that remain. The reduced firing is due to the degradation of perineuronal nets (PNNs) that surround FSNs. We show that PNNs decrease specific membrane capacitance of FSNs permitting them to fire action potentials at supra-physiological frequencies. Tumor-released proteolytic enzymes degrade PNNs, resulting in increased membrane capacitance, reduced firing, and hence decreased GABA release. These studies uncovered a hitherto unknown role of PNNs as an electrostatic insulator that reduces specific membrane capacitance, functionally akin to myelin sheaths around axons, thereby permitting FSNs to exceed physiological firing rates. Disruption of PNNs may similarly account for excitation-inhibition imbalances in other forms of epilepsy and PNN protection through proteolytic inhibition may provide therapeutic benefits.

AI snapshot

Written from the paper’s full text.

TL;DR

In a patient-derived glioma mouse model, peritumoral fast-spiking interneurons (FSNs) lose perineuronal nets (PNNs) through tumor-released MMPs, increasing membrane capacitance and reducing firing. PNNs act as an electrostatic insulator that lowers specific membrane capacitance, allowing FSNs to sustain supra-physiological firing; MMP inhibition preserves PNNs and FSN excitability.

Key findings

  • Peritumoral cortex within 0.6 mm showed distance-dependent neuronal loss: NeuN+ density at 0.0–0.2 mm was 9.25 ± 1.63 vs contralateral 25.41 ± 0.68 and sham 26.12 ± 0.94; PV+ density at 0.0–0.2 mm was 0.58 ± 0.1 vs contralateral 2.52 ± 0.15 and sham 2.6 ± 0.25; WFA+ PNN density at 0.0–0.2 mm was 0.87 ± 0.16 vs contralateral 2.75 ± 0.13 and sham 2.78 ± 0.17.
  • Glioma-released gelatinases/MMPs degraded PNNs: gelatinase activity was higher in glioma mass (1851.47 ± 120.17) and PTC than sham (669.96 ± 34.56); the MMP inhibitor GM6001 reduced gelatinase activity and preserved PNN structure, with more WFA peaks in PNNs (GM6001 15.16 ± 0.65 vs GBM22 7.08 ± 0.63).
  • Peritumoral FSNs had higher membrane capacitance (43.84 ± 3.74 pF) than contralateral (28.82 ± 2.14 pF) and sham (30.11 ± 1.99 pF), and firing frequency was reduced by ~50%; GM6001 restored FSN capacitance (28.27 ± 1.36 pF) and input–output curves toward sham.
  • ChABC digestion of PNNs phenocopied the FSN changes: capacitance increased ~20–25%, maximal firing frequency fell ~20%, and real-time ChABC increased Cm from 43.53 ± 2.70 to 55.76 ± 3.43 pF while max AP frequency fell from 406.62 ± 14.39 to 322.5 ± 30.27 Hz; PNN degradation also shortened latency to ictal-like activity (control 73.67 ± 6.69 min vs ChABC 38.83 ± 3.40 min).

Methods

  • Patient-derived glioma xenolines GBM22 (glutamate-releasing via SXC) and GBM14 (non-glutamate-releasing) were implanted into C.B.17 scid mouse cortex; sham and contralateral controls were used, along with an astrocyte-specific β1-integrin knockout mouse model of astrogliosis and GM6001 MMP-inhibitor treatment.
  • Immunohistochemistry and confocal imaging quantified NeuN, PV, WFA-labeled PNNs, and GFAP; in situ zymography measured MMP-2/9 gelatinase activity; PNN integrity was assessed by WFA intensity and line-profile peak counts.
  • Acute slice patch-clamp electrophysiology recorded excitatory neurons and FSNs, with Lucifer yellow postrecording identification; PNNs were digested with ChABC, and Hodgkin–Huxley/Neuronify modeling plus ANOVA/t-tests were used for analysis.

Limitations

  • Stated in the paper: experimental limitations including incubation duration and low enzymatic activity prevented sufficient PNN degradation using an MMP cocktail, so ChABC was used instead.
  • Stated in the paper: PNN degradation may also alter synaptic activity and network excitability beyond the membrane-capacitance mechanism, and additional studies are warranted.
  • Evident from the text: the core evidence comes from mouse glioma models and acute slices, not human tissue; ChABC degrades CSPGs broadly rather than only PNNs, and some mechanistic links between tumor-released MMPs and PNN loss rely on spatial correlation plus inhibitor rescue rather than direct causal isolation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-018-07113-0

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 52 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    The reduced firing frequency of FSNs in GBM22 PTC is not due to altered Vm, as clamping at −60, −65, or −70 mV does not change their firing frequency.

    “This was not due to altered Vm of FSNs in GBM22 PTC as clamping them at −60, −65, or −70 mV did not change their firing frequency (Supplementary Fig. 5a).”
    Quote in the paperSubstantial claim
  • Findingnone given

    Peritumoral PNN degradation is primarily attributed to glioma-released MMPs (MMP-2, MMP-3, and MMP-9).

    “As our results attribute peritumoral PNN degradation primarily to glioma-released MMPs (MMP-2, MMP-3, and MMP-9), we used a cocktail of these MMPs to degrade PNNs experimentally.”
    Quote in the paperSubstantial claim
  • Findingown data

    Peritumoral FSNs show significantly higher membrane capacitance (Cm).

    “but showed significantly higher Cm (Fig. 6h).”
    Quote in the paperSubstantial claim
  • Findingown data

    Spike frequency in GBM22 contralateral half remains similar to sham.

    “Spike frequency in GBM22 contralateral half remained similar to sham (Supplementary Fig. 4e).”
    Quote in the paperNot a substantial claim
  • Findingown data

    Peritumoral FSNs are depolarized.

    “Peritumoral FSNs were similarly depolarized (Fig. 6g)”
    Quote in the paperNot a substantial claim
  • May combine two claims. 57
  • Classified as probably not a substantial claim. 25
  • The quote only partly states this claim. 1
  • May combine two claims.

    Findingown data

    GBM14 implantation nullifies changes in firing threshold and Vm of PTC neurons, with no apparent difference to sham or contralateral brains.

    “This indeed nullified the changes in firing threshold and Vm with no apparent difference to sham or contralateral brains (Fig. 6e, Supplementary Fig. 4b, c).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The membrane capacitance (Cm) of FSNs in GM6001-treated PTC was lower than in nontreated PTC but similar to sham.

    “Lower Cm of FSNs in the PTC of GM6001-treated (28.27 ± 1.36, n = 20(5)) than nontreated (43.84 ± 3.74, n = 13(8)), but similar to sham (30.11 ± 1.99, n = 15(6)).”
    • Also stated in: § Biophysical changes in peritumoral neurons · boosted
      “Most importantly, FSNs in GM6001-treated mice brain slices showed profound differences in Cm and input−output curves, and both were essentially identical to the sham (Fig. 7b, e, f).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In GBM14, WFA staining shows largely intact PNNs even in close proximity to the tumor (0.2-0.4 mm), whereas in GBM22, PNNs are largely degraded.

    “In GBM14, WFA staining showed largely intact PNNs even in close proximity to the tumor (0.2–0.4 mm), whereas in GBM22, PNNs were largely degraded (Fig. 3a, c).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The Rin of excitatory neurons in GM6001-treated PTC was not significantly different from nontreated PTC but was different from sham.

    “Input resistance (Rin) of excitatory neurons in GM6001-treated PTC (244.64 ± 9.24, n = 27(6)) was not significantly different than in nontreated PTC (288.18 ± 15.82, n = 23(10)), but than in sham (298.63 ± 14.47, n = 39(10)).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    GM6001-treated mice retain structural integrity of PNNs in the PTC, as evident by PNNs around cell body and proximal dendrites, more WFA peaks, and higher WFA intensity compared to sham-treated mice.

    “Indeed, GM6001-treated mice retained structural integrity of PNNs in the PTC (Fig. 5f−i) as evident by the presence of PNNs around cell body and proximal dendrites (Fig. 5f, middle panels), more WFA peaks (Fig. 5g, h), and higher WFA intensity (Fig. 5i) compared to sham-treated mice.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    GM6001 treatment reduces gelatinase activity within the glioma and in the PTC.

    “Confirming our prediction, GM6001 treatment reduced gelatinase activity within the glioma (Fig. 5a, middle panels) and in the PTC (Fig. 5d).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The PTC in close proximity to the tumor (<0.3 mm) shows disintegrated PNNs surrounded by highly reactive astrocytes, while essentially intact PNNs are observed around equally high GFAP-expressing astrocytes in more distal (>0.6 mm) PTC.

    “while the PTC in close proximity to the tumor (<0.3 mm) showed disintegrated PNNs surrounded by highly reactive astrocytes (Fig. 4a (bottom square), Fig. 4b, c), we observed essentially intact PNNs around equally high GFAP (glial fibrillary acidic protein) expressing astrocytes in more distal (>0.6 mm) PTC (Fig. 4a (top square), 4b, c).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The action potential (AP) frequency of FSNs in GM6001-treated PTC was higher than in nontreated PTC but not higher than in sham.

    “Higher AP frequency of FSNs in GM6001-treated PTC (n = 12(5)) than in nontreated PTC (n = 18(11)) but not than in sham (n = 10(7)).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    WFA intensity peaks are significantly reduced in the line profile of peritumoral PNNs, indicating large holes in the PNN.

    “We confirmed the same by observing significant reduction in the WFA intensity peaks (see methods) in the line profile of peritumoral PNNs, an indicative of large holes in the PNN (Fig. 2c−e).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Membrane capacitance and input resistance of PTC neurons remain unaffected.

    “however, their membrane capacitance (Cm) and input resistance (Rin) remained unaffected (Fig. 6b, c).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The resting membrane potential (Vm) of FSNs in GM6001-treated PTC was not significantly different from nontreated GBM22 PTC but was significantly different from sham.

    “Unaltered resting membrane potential (Vm) of FSNs in the PTC of GM6001-treated (62.88 ± 1.40, n = 18(5)) than in nontreated (GBM22) PTC (61.67 ± 1.01, n = 12(8)), but significantly different than in sham (69.85 ± 0.67, n = 7(6)).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The gradient of NeuN+ cell loss extends up to 0.6 mm from the tumor margin, with significantly lower cell density compared to sham and contralateral brains.

    “The gradient of NeuN+ cell loss was observed up to 0.6 mm from the tumor margin, the furthest distance evaluated, with significantly lower cell density compared to sham and contralateral brains (Fig. 1a).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Excitatory neurons in GM6001-treated PTC were depolarized relative to nontreated PTC and had Vm similar to sham.

    “Resting membrane potential (Vm) of excitatory neurons in GM6001-treated PTC (66.62 ± 0.77, n = 27(8)) remained similar to sham (67.02 ± 0.38, n = 98(15)), but was significantly higher than the nontreated PTC (61.49 ± 0.86, n = 80(11)).”
    • Also stated in: § Biophysical changes in peritumoral neurons · plain
      “Excitatory neurons in GM6001-treated PTC were depolarized (Fig. 7g);”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The input−output curve of excitatory neurons in GM6001-treated PTC showed lower excitability with small current injections, similar to sham, but somewhat increased excitability with larger current injections than sham.

    “Moreover, the input−output curve showed a lower excitability with small current injections, similar to that of sham, yet still showed somewhat increased excitability with larger current injections than sham (Fig. 7k, l).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Excitatory neurons gradually depolarized during ChABC superfusion.

    “Excitatory neurons gradually depolarized during ChABC superfusion (Supplementary Fig. 8a, b (right)), a phenomenon we did not study further.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In the Hodgkin−Huxley simulation, maximal firing rate increased nonlinearly with increasing stimulation and decreased progressively with increasing specific membrane capacitance.

    “Maximal firing rate (z-axis) increased nonlinearly with increasing stimulation (y-axis), and decreased progressively with increasing specific membrane capacitance (x-axis).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The first-order Hodgkin−Huxley approximation and Neuronify model with identical electrical properties adequately represent the biophysical behavior of FSNs.
  • May combine two claims.

    Findingown data

    There is a 2-5-fold decrease in PV interneuron density within 0.6 mm of glutamate-releasing tumor, suggesting excitotoxic loss.

    “In agreement with prior studies, we observed a 2–5-fold decrease in the PV interneurons density within 0.6 mm of glutamate-releasing tumor suggesting their excitotoxic loss.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    ChABC pretreatment significantly shortened the latency of ictal-like events but not interictal-like events.

    “ChABC pretreatment significantly shortened the latency of ictal-like events (Fig. 9e−g) but not interictal-like events (Fig. 9f).”
    • Also stated in: § PNN degradation facilitates cortical epileptiform activity · plain
      “ictal-like activity (control, 73.67 ± 6.69 min, n = 12(6); ChABC-treated, 38.83 ± 3.40 min, n = 8(5); ***P < 0.001, Welch's t test).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Surviving PV interneurons show ~50% reduction in firing frequency, a phenomenon independent of tumor-released Glu.

    “Interestingly, the surviving PV interneurons show ~50% reduction in firing frequency, a phenomenon that was independent of the tumor-released Glu.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Peritumoral excitatory neurons are significantly depolarized, have a reduced activation threshold and increased discharge frequency, but only when proximal to a tumor that expresses the Glu-releasing SXC transporter.

    “Prior studies had already implicated the assiduous release of Glu from the tumor as instrumental, and we indeed find that peritumoral excitatory neurons are significantly depolarized, have a reduced activation threshold and increased discharge frequency but only when proximal to a tumor that expresses the Glu-releasing SXC transporter.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Action potential amplitudes shortened as firing frequency increased.

    “We observed that the amplitudes of APs shortened as the firing frequency increased; therefore, we set a minimum 15 mV deflection from the steady-state response as a qualifying criterion for a spike to be identified as an AP.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    The saturating/maximum firing frequency supported by fast-spiking neurons (FSNs) in the experimental conditions was achieved by injecting 400-500 pA.

    “The observed saturating/maximum firing frequency was found to be achieved by injecting 400−500 pA; therefore, we capped the highest injected current to 500 pA.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Glutamate release is necessary but insufficient to drive peritumoral epilepsy; an additional loss of GABAergic inhibition is required.

    “Glu release, while necessary, is insufficient to drive peritumoral epilepsy3. Rather an additional loss of GABAergic inhibition is required”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [3] Campbell, S. L. et al. GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor‐associated epilepsy. Glia 63, 23–36 (2015). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    PNNs act as an electrostatic insulator that reduces specific membrane capacitance, functionally akin to myelin sheaths around axons, thereby permitting FSNs to exceed physiological firing rates.

    “These studies uncovered a hitherto unknown role of PNNs as an electrostatic insulator that reduces specific membrane capacitance, functionally akin to myelin sheaths around axons, thereby permitting FSNs to exceed physiological firing rates.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Enhanced glutamatergic drive in tumor-associated epilepsy results from glutamate released from gliomas via the system Xc transporter (SXC) encoded by SLC7A11, which is upregulated in about 54% of glioma patients.

    “The enhanced glutamatergic drive is the result of glutamate (Glu) being assiduously released from gliomas via system Xc transporter (SXC) encoded by the SLC7A11 gene that is upregulated in about 54% of glioma patients4.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [4] Robert, S. M. et al. SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. Sci. Transl. Med. 7, 289ra286 (2015). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The cellular and molecular changes underlying tumor-associated epilepsy collectively point to a decrease in GABAergic and increase in glutamatergic transmission as the major contributors.

    “The cellular and molecular changes underlying tumor-associated epilepsy collectively point to a decrease in GABAergic and increase in glutamatergic transmission as the major contributors3–6.”
    Quote in the paperNot a substantial claim0 of 4 sources checked
    • cites [3] Campbell, S. L. et al. GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor‐associated epilepsy. Glia 63, 23–36 (2015). source

      Not checked in the free run.

    • cites [4] Robert, S. M. et al. SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. Sci. Transl. Med. 7, 289ra286 (2015). source

      Not checked in the free run.

    • cites [5] Pallud, J. et al. Cortical GABAergic excitation contributes to epileptic activities around human glioma. Sci. Transl. Med. 6, 244ra289 (2014). source

      Not checked in the free run.

    • cites [6] Buckingham, S. C. et al. Glutamate release by primary brain tumors induces epileptic activity. Nat. Med. 17, 1269–1274 (2011). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    Tumor-released proteolytic enzymes degrade PNNs, resulting in increased membrane capacitance, reduced firing, and hence decreased GABA release.

    “Tumor-released proteolytic enzymes degrade PNNs, resulting in increased membrane capacitance, reduced firing, and hence decreased GABA release.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    PNNs decrease specific membrane capacitance of FSNs, permitting them to fire action potentials at supra-physiological frequencies.

    “We show that PNNs decrease specific membrane capacitance of FSNs permitting them to fire action potentials at supra-physiological frequencies.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    About 80% of PV+ FSNs are surrounded by perineuronal nets (PNNs).

    “About 80% of PV+ FSNs14 are surrounded by perineuronal nets (PNNs)”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [14] Carulli, D. et al. Animals lacking link protein have attenuated perineuronal nets and persistent plasticity. Brain 133, 2331–2347 (2010). source

      Not checked in the free run.

  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    PNNs may restrict local ionic concentration due to a high density of negatively charged glycosaminoglycans, thereby regulating the microenvironment of FSNs and influencing their intrinsic properties.

    “PNNs may also restrict local ionic concentration due to a high density of their negatively charged constituent glycosaminoglycans (GAGs)18, thereby regulating the microenvironment of FSNs and influencing their intrinsic properties19.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [18] Morawski, M. et al. Ion exchanger in the brain: quantitative analysis of perineuronally fixed anionic binding sites suggests diffusion barriers with ion sorting properties. Sci. Rep. 5, 16471 (2015). source

      Not checked in the free run.

    • cites [19] Härtig, W. et al. Cortical neurons immunoreactive for the potassium channel Kv3. 1b subunit are predominantly surrounded by perineuronal nets presumed as a buffering system for cations. Brain Res. 842, 15–29 (1999). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    Tumor-associated seizures are the consequence of impaired GABAergic inhibition due to an overall loss of peritumoral fast spiking interneurons (FSNs) and a significantly reduced firing rate of those that remain.

    “We show that tumor-associated seizures are the consequence of impaired GABAergic inhibition due to an overall loss of peritumoral fast spiking interneurons (FSNs) concomitant with a significantly reduced firing rate of those that remain.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    The PTC exhibits a spatial gradient of higher to lower gelatinase activity from the glioma border to the distal PTC that is negatively correlated with WFA intensity, suggesting the tumor as the likely source of MMPs.

    “PTC exhibited a spatial gradient of higher to lower gelatinase activity from the glioma border to the distal PTC (Fig. 5b) that appeared negatively correlated with the WFA intensity (Fig. 5c), suggesting the tumor as the likely source of MMPs.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Approximately 10% of all NeuN+ neurons in cortex are PV+.

    “In agreement with the literature24–26, ~10% of all NeuN+ neurons in cortex were PV+ (Fig. 1b, c)”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [24] Ren, J., Aika, Y., Heizmann, C. & Kosaka, T. Quantitative analysis of neurons and glial cells in the rat somatosensory cortex, with special reference to GABAergic neurons and parvalbumin-containing neurons. Exp. Brain Res. 92, 1–14 (1992). source

      Not checked in the free run.

    • cites [25] Le Magueresse, C. & Monyer, H. GABAergic interneurons shape the functional maturation of the cortex. Neuron 77, 388–405 (2013). source

      Not checked in the free run.

    • cites [26] Beaulieu, C. Numerical data on neocortical neurons in adult rat, with special reference to the GABA population. Brain Res. 609, 284–292 (1993). source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Seizures originate from the PTC, and previous studies show altered excitation−inhibition balance in the PTC due to changes in glutamatergic and GABAergic activity.

    “Seizures originate from the PTC, and previous studies3,5,6 show altered excitation−inhibition balance in the PTC due to changes in glutamatergic and GABAergic activity.”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [3] Campbell, S. L. et al. GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor‐associated epilepsy. Glia 63, 23–36 (2015). source

      Not checked in the free run.

    • cites [5] Pallud, J. et al. Cortical GABAergic excitation contributes to epileptic activities around human glioma. Sci. Transl. Med. 6, 244ra289 (2014). source

      Not checked in the free run.

    • cites [6] Buckingham, S. C. et al. Glutamate release by primary brain tumors induces epileptic activity. Nat. Med. 17, 1269–1274 (2011). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    Real-time digestion of PNNs suggests that PNNs act as an insulator that decreases specific membrane capacitance of the cell, thereby permitting an increase in the maximally achievable firing rate of FSNs.

    “Importantly, real-time digestion of PNNs suggests that PNNs act as an insulator that decreases specific membrane capacitance of the cell thereby permitting an increase in the maximally achievable firing rate of FSNs.”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Study design and conductown data

    Experimental limitations including incubation duration and low enzymatic activity prevented sufficient PNN degradation with the MMP cocktail.

    “Unfortunately, experimental limitations including incubation duration and low enzymatic activity prevented us to achieve sufficient PNN degradation.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    PNN degradation alone is sufficient to reduce the firing frequency of FSNs, thereby decreasing inhibitory tone.

    “We show that PNN degradation alone is sufficient to reduce the firing frequency of FSNs thereby decreasing inhibitory tone”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Preventing PNN degradation significantly rescued the biophysical characteristics of inhibitory neurons but did not affect excitatory neurons, which were still under the influence of tumor-released glutamate.

    “Preventing PNN degradation significantly rescued the biophysical characteristics of inhibitory neurons but without affecting excitatory neurons, which were still under the influence of tumor-released glutamate.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The elevation in glioma-released glutamate persists in GM6001-treated animals and continues to drive heightened excitability of excitatory neurons.
  • May combine two claims.

    Interpretationown data

    Neither resting membrane potential nor input−output curve of FSNs can be attributed to tumor-released Glu, as they are identical in neurons with disintegrated PNNs recorded in PTCs of GBM14 and GBM22.

    “In contrast to excitatory cells, neither resting membrane potential nor input−output curve (Fig. 6j−l) could be attributed to the tumor-released Glu as they were identical in neurons with disintegrated PNNs recorded in the PTCs of GBM14 and GBM22-implanted brains (Fig. 6k).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Tumor-secreted molecules, likely Glu and proteolytic enzymes, cause a distance-dependent loss of interneurons and degradation of PNNs, respectively.

    “Taken together, these data suggest that tumor-secreted molecules, likely Glu and proteolytic enzymes, cause a distance-dependent loss of interneurons and degradation of PNNs, respectively.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Changes in the excitability of FSNs appear intrinsic and are associated with disintegration of PNNs and a ~25% increase in cell capacitance as the primary differences between PTC and control cortex.

    “In contrast, changes in the excitability of FSNs appear intrinsic, and are associated with disintegration of PNNs and ~25% increase in cell capacitance as the primary differences between PTC and control cortex.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Spike frequency of excitatory neurons in GBM22 PTC is significantly reduced on blocking glutamatergic neurotransmission, confirming they are driven by glioma-released Glu rather than intrinsic to the cell.

    “In addition, the spike frequency of excitatory neurons in GBM22 PTC was significantly reduced on blocking the glutamatergic neurotransmission, further confirming them driven by glioma-released Glu rather than intrinsic to the cell (Supplementary Fig. 5b).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Metalloproteinase inhibitors prevented seizures and MMP-9 knockout mice were less susceptible to pentylenetetrazole-induced seizures.

    “Moreover, metalloproteinase inhibitors prevented seizures51 and MMP-9 knockout mice were less susceptible to pentylenetetrazole-induced seizures52.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [51] Pollock, E., Everest, M., Brown, A. & Poulter, M. O. Metalloproteinase inhibition prevents inhibitory synapse reorganization and seizure genesis. Neurobiol. Dis. 70, 21–31 (2014). source

      Not checked in the free run.

    • cites [52] Wilczynski, G. M. et al. Important role of matrix metalloproteinase 9 in epileptogenesis. J. Cell. Biol. 180, 1021–1035 (2008). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    Experimental digestion of PNNs in normal brain phenocopied the change in capacitance and the observed excitability changes.

    “Experimental digestion of PNNs in normal brain phenocopied the change in capacitance and the observed excitability changes.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Heightened MMP activity has been reported in other models of epilepsy, with elevated MMP level associated with epileptiform activity.

    “While we suggest a pivotal role for the MMP activity in glioma-associated epilepsy, heightened MMP activity has also been reported in other models of epilepsy46 with elevated MMP level being associated with epileptiform activity47–50.”
    Quote in the paperNot a substantial claim0 of 5 sources checked
    • cites [46] Dubey, D. et al. Increased metalloproteinase activity in the hippocampus following status epilepticus. Epilepsy Res. 132, 50–58 (2017). source

      Not checked in the free run.

    • cites [47] Jourquin, J. et al. Neuronal activity‐dependent increase of net matrix metalloproteinase activity is associated with MMP‐9 neurotoxicity after kainate. Eur. J. Neurosci. 18, 1507–1517 (2003). source

      Not checked in the free run.

    • cites [48] Kim, G. W. et al. The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus. Neurobiol. Dis. 36, 169–180 (2009). source

      Not checked in the free run.

    • cites [49] Szklarczyk, A., Lapinska, J., Rylski, M., McKay, R. D. & Kaczmarek, L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J. Neurosci. 22, 920–930 (2002). source

      Not checked in the free run.

    • cites [50] Takács, E. et al. Matrix metalloproteinase-9 activity increased by two different types of epileptic seizures that do not induce neuronal death: a possible role in homeostatic synaptic plasticity. Neurochem. Int. 56, 799–809 (2010). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    The PNN that extends from the proximal dendrites across the cell body to the axon hillock increases membrane thickness, which in turn decreases specific membrane capacitance.

    “Akin to the myelin sheaths surrounding axons, the PNN that extends from the proximal dendrites across the cell body to the axon hillock increases the membrane thickness, which in turn decreases the specific membrane capacitance.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    PNN damage is primarily attributed to the proteolytic activity of glioma-released MMPs and consequently caused the cell's membrane capacitance to increase.

    “PNN damage was found to be primarily attributed to the proteolytic activity of glioma-released MMPs and consequently caused the cell’s membrane capacitance to increase.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    PNNs act as an electrostatic insulator that decreases the cell's effective membrane capacitance and concomitantly increases the cell's maximally attainable firing frequency, which is directly linked to GABA release and maintenance of inhibitory tone.

    “Further biophysical analysis and modeling results revealed that the PNNs must act as an electrostatic insulator that decreases the cell’s effective membrane capacitance and concomitantly increase the cell’s maximally attainable firing frequency, which is directly linked to GABA release and maintenance of inhibitory tone.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The first-order Hodgkin−Huxley approximation and Neuronify model with identical electrical properties adequately represent the biophysical behavior of FSNs.
  • May combine two claims.

    Interpretationown data

    An intact PNN reduces membrane capacitance and is essential to allow FSNs to sustain their maximum firing frequency.

    “Taken together, these data suggest that an intact PNN reduces membrane capacitance and is essential to allow FSNs to sustain their maximum firing frequency.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    PNNs and CSPGs protect neurons from oxidative stress and glutamate excitotoxicity, and combined actions of glioma-released proteases and Glu might explain the selective vulnerability of PV neurons over principal neurons in the PTC.

    “PNNs and CSPGs play crucial roles in protecting neurons from oxidative stress33 and glutamate excitotoxicity42 and combined actions of glioma-released proteases and Glu might explain the selective vulnerability of PV neurons over principle neurons in the PTC.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [33] Okamoto, M., Mori, S. & Endo, H. A protective action of chondroitin sulfate proteoglycans against neuronal cell death induced by glutamate. Brain Res. 637, 57–67 (1994). source

      Not checked in the free run.

    • cites [42] Rempe, R. G. et al. Matrix metalloproteinase-mediated blood−brain barrier dysfunction in epilepsy. J. Neurosci. 38, 4301–4315 (2018). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationcitation

    PNN degradation may also alter synaptic activity and hence network excitability.

    “However, it is important to recognize that in addition to changes in the excitability of inhibitory neurons as suggested here and by others55, PNN degradation may also alter synaptic activity56 and hence network excitability.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [55] Balmer, T. S. Perineuronal nets enhance the excitability of fast-spiking neurons. eNeuro 3, ENEURO.0112-0116.2016 (2016). source

      Not checked in the free run.

    • cites [56] McRae, P. A. & Porter, B. E. The perineuronal net component of the extracellular matrix in plasticity and epilepsy. Neurochem. Int. 61, 963–972 (2012). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given

    ChABC degrades CSPGs in the interstitial matrix and PNNs irrespective of their structural arrangement.

    “ChABC degrades CSPGs in the interstitial matrix and PNNs irrespective of their structural arrangement.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Staley and colleagues demonstrated that CSPG digestion changes the transmembrane Cl− gradient, which can alter GABAergic neurotransmission.

    “Staley and colleagues demonstrated that CSPGs digestion changes the transmembrane Cl− gradient, which can alter GABAergic neurotransmission20.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [20] Glykys, J. et al. Local impermeant anions establish the neuronal chloride concentration. Science 343, 670–675 (2014). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    Gliomas act as a localized source of seizure-provoking Glu and PNN-degrading metalloproteinases, establishing a gradient of spread that explains the observed gradient of excitotoxic cell loss and PNN destruction decreasing with distance from the tumor.

    “Gliomas act as a localized source of seizure provoking Glu and PNN degrading metalloproteinases28 thereby establishing a gradient of spread, which explains the observed gradient of excitotoxic cell loss and PNN destruction that decreases with distance from the tumor.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [28] Rao, J. S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 3, 489–501 (2003). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Others have suggested altered lateral mobility of AMPAR or changes in local diffusion of Ca2+ in brain tissue following PNN degradation.

    “Others have suggested altered lateral mobility of AMPAR53 or changes in the local diffusion of Ca2+ in brain tissue54 following PNN degradation.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [53] Frischknecht, R. et al. Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity. Nat. Neurosci. 12, 897–904 (2009). source

      Not checked in the free run.

    • cites [54] Hrabětová, S., Masri, D., Tao, L., Xiao, F. & Nicholson, C. Calcium diffusion enhanced after cleavage of negatively charged components of brain extracellular matrix by chondroitinase ABC. J. Physiol. 587, 4029–4049 (2009). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    GM6001 increased the number of FSNs, most likely due to the known neuroprotective effect of PNNs shielding FSNs from glutamate excitotoxicity.

    “In addition, GM6001 increased the number of FSNs most likely due to the known neuroprotective effect of the PNNs33 shielding FSNs from glutamate excitotoxicity33.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [33] Okamoto, M., Mori, S. & Endo, H. A protective action of chondroitin sulfate proteoglycans against neuronal cell death induced by glutamate. Brain Res. 637, 57–67 (1994). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    The presence of PNN increases maximal sustainable firing frequency and greatly enhances evoked activity even at lower frequencies.

    “Hence, these data suggest that not only does the presence of PNN increases maximal sustainable firing frequency, but also the evoked activity is indeed greatly enhanced even at lower frequencies.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The first-order Hodgkin−Huxley approximation and Neuronify model with identical electrical properties adequately represent the biophysical behavior of FSNs.
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.

    Interpretationnone given

    Other populations of FSNs in brain may be similarly modulated by PNNs and similarly vulnerable to enzymatic damage of PNNs following injury and disease.

    “Other populations of FSNs in brain may be similarly modulated by PNNs, and similarly vulnerable to enzymatic damage of PNNs following injury and disease.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    PNN tunes the cell's membrane capacitance thereby modulating its firing frequency.

    “As illustrated in summary Supplementary Fig. 10, our data suggest that PNN tunes cell’s membrane capacitance thereby modulating its firing frequency.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Membrane capacitance and series resistance were not compensated unless otherwise stated.

    “The membrane capacitance (Cm) and series resistance were not compensated unless otherwise stated.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    A line profile intensity graph showing an almost flat line with only a few low intensity peaks indicates a disintegrated PNN by glioma.

    “A line profile intensity graph showing almost flat line with only few low intensity peaks indicates disintegrated PNN by glioma as exemplified in Fig. 2d.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    All animal procedures were approved and performed in accordance with ethical guidelines set by Virginia Tech Institutional Animal Care and Use Committee (IACUC).

    “All animal procedures were approved and performed in accordance with the ethical guidelines set by Virginia Tech Institutional Animal Care and Use Committee (IACUC).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Glu may cause an increase in MMP expression and activity level.

    “Note that Glu may also cause an increase in MMP expression and activity level as reported by a recent study41.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [41] Lukes, A., Mun-Bryce, S., Lukes, M. & Rosenberg, G. A. Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol. Neurobiol. 19, 267–284 (1999). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The model methodology, including model interactions and parameter values, has been used in recent studies.

    “This similar methodology, both model interactions and parameter values, has been used in recent studies61–63.”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [61] Guerrier, C. & Holcman, D. Hybrid Markov-mass action law model for cell activation by rare binding events: application to calcium induced vesicular release at neuronal synapses. Sci. Rep. 6, 35506 (2016). source

      Not checked in the free run.

    • cites [62] Howell, B., Medina, L. E. & Grill, W. M. Effects of frequency-dependent membrane capacitance on neural excitability. J. Neural Eng. 12, 056015 (2015). source

      Not checked in the free run.

    • cites [63] Weinberg, S. H. Membrane capacitive memory alters spiking in neurons described by the fractional-order Hodgkin−Huxley model. PLoS ONE 10, e0126629 (2015). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Study design and conductnone given

    The data are sufficiently normally distributed and the variance within groups is sufficiently similar to be used for parametric tests.

    “Data are sufficiently normal distributed and variance within groups is sufficiently similar to be used for parametric tests.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductown data

    Real-time ChABC superfusion at 1 U/ml for 50 min at 32-33 °C reliably degraded PNNs but left identifiable traces around FSNs to confirm the presence of PNNs prior to digestion.

    “This protocol also reliably degraded PNNs but left identifiable traces around the FSNs to confirm the presence of PNNs around patched cells prior to the digestion (Supplementary Fig. 7).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductown data

    ChABC treatment at 0.5 U/ml for 45 min at 33 °C reliably degraded PNNs but spared traces around FSNs, allowing identification of PNN-positive cells.

    “These parameters of PNNs digestion by ChABC (enzyme concentration—0.5 U/ml, incubation time—45 min, incubation temperature—33 °C) reliably degraded PNNs but spared traces around the FSNs thereby allowing the identification of PNN-positive cells (Supplementary Fig. 6a, b).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    Glutamatergic neurotransmission was blocked by superfusing D-AP-5 and CNQX, and the blockage was confirmed by the disappearance of spontaneous EPSCs.

    “For few experiments, we superfused ACSF containing 50 µM D-2-amino-5-phosphonovalerate (D-AP-5) and 20 µM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) to block glutamatergic neurotransmission and confirmed the blockage by observing disappearance of spontaneous EPSCs.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Staining was performed in a large batch of duplicate sections from 5 to 7 mice of each treatment group to minimize procedure-related variability.

    “To minimize procedure-related variability, we preformed staining in a large batch of duplicate sections from 5 to 7 mice of each treatment group.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    The Hodgkin-Huxley model was first described by Hodgkin and Huxley and modified by Abbott and Kepler.

    “This model was first described in the seminal work by Hodgkin and Huxley, and modified by Abbot and Kepler59,60.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [59] Abbott, L. & Kepler, T. B. Model neurons: from Hodgkin−Huxley to Hopfield. In Statistical Mechanics of Neural Networks (ed. Garrido, I.) (Springer, Berlin, 1990).

      Not checked in the free run.

    • cites [60] Hodgkin, A. L. & Huxley, A. F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. 117, 500–544 (1952). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    PNNs are stable structures known to lock synapses in place upon closure of the developmental window of plasticity, and several CNS pathologies present with upregulated ECM and PNN remodeling enzymes including MMPs.

    “Although PNNs are stable structures and known to lock synapses in place upon closure of the developmental window of plasticity17,38,39, several CNS pathologies40, including glioma and epilepsy, present with upregulated ECM and PNN remodeling enzymes including MMPs.”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [17] Tsien, R. Y. Very long-term memories may be stored in the pattern of holes in the perineuronal net. Proc. Natl. Acad. Sci. USA 110, 12456–12461 (2013). source

      Not checked in the free run.

    • cites [38] Hu, H., Gan, J. & Jonas, P. Fast-spiking, parvalbumin + GABAergic interneurons: From cellular design to microcircuit function. Science 345, 1255263 (2014). source

      Not checked in the free run.

    • cites [39] Pizzorusso, T. et al. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 298, 1248–1251 (2002). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Different patterns of PV and NeuN intensity peaks flanked by WFA peaks indicate whether a cell is present inside the PNN and the status of the PNN.

    “Different patterns of PV and NeuN intensity peaks flanked by WFA peaks indicate whether a cell is present inside the PNN and the status of PNN.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Potential damage to PNNs during patching was minimized by applying minimum positive pressure while approaching cells.

    “A potential damage to the PNNs was minimized during the patching procedure by applying minimum positive pressure while approaching cells.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationcitation

    The aforementioned mechanisms could alter the excitation−inhibition balance in favor of seizures and may contribute to a loss of inhibition in tumor-associated cortex.

    “The aforementioned mechanisms could alter the excitation−inhibition balance in favor of seizures and may well contribute to a loss of inhibition in tumor-associated cortex.”
    Quote in the paperSubstantial claim
74 of 74
  • The paper relies on this without support.

    The elevation in glioma-released glutamate persists in GM6001-treated animals and continues to drive heightened excitability of excitatory neurons.

    “Note, however, that under these conditions the elevation in glioma-released glutamate remains a driver of heightened excitability in GM6001-treated animals.”
  • The paper relies on this without support.

    The first-order Hodgkin−Huxley approximation and Neuronify model with identical electrical properties adequately represent the biophysical behavior of FSNs.

    “we employed a computer simulation to generate a first-order approximation to the Hodgkin−Huxley (HH) differential equation model (Supplementary Fig. 9a, b).”
2 of 2

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Neuronal density at 0.4-0.6 mm falls outside the stated range

    Minor

    The text says GBM22 reduced NeuN+ cell density to about 50-60% throughout the 0.2-0.6 mm region, but Fig. 1e reports 72.99% for the 0.4-0.6 mm bin.

  • GM6001-treated excitatory neurons are called depolarized despite sham-like potential

    Minor

    The results text calls these neurons depolarized, but Fig. 7g says their resting potential remained similar to sham and differed from nontreated PTC.

2 of 2

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Abbott, L. & Kepler, T. B. Model neurons: from Hodgkin−Huxley to Hopfield. In Statistical Mechanics of Neural Networks (ed. Garrido, I.) (Springer, Berlin, 1990).

Cited by

Sorted by citations

Authors
Tewari, B. P., Chaunsali, L., Campbell, S. L., Patel, D. C., Goode, A. E., & Sontheimer, H.
Affiliations
Carilion Clinic (US)
Corresponding author
Sontheimer, Harald
Venue
Nature Communications
Published
2018-11-09
Volume
9
Issue
1
Pages
4724-4724
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2900125538
Cited by
208
References
64
Citations by year
2026: 24 · 2025: 38 · 2024: 28 · 2023: 30 · 2022: 31 · 2021: 24 · 2020: 20 · 2019: 13
FWCI
11.14
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • VTechWorks (Virginia Tech) (submittedVersion, cc-by)
Funders
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R01NS052634, R01NS036692, R01NS082851)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural dynamics and brain function
Keywords
perineuronal nets, fast-spiking interneurons, membrane capacitance, tumor-associated epilepsy, GABAergic inhibition, proteolytic enzymes, tumor microenvironment, excitatory-inhibitory imbalance, epilepsy treatment
MeSH terms
Action Potentials, Animals, Brain Neoplasms, Cell Membrane, Disease Models, Animal, Epilepsy, Extracellular Matrix, Female, Glioma, Gliosis, Interneurons, Male, Mice, Nude, Peptide Hydrolases, Mice, SCID, Electric Capacitance, Biophysical Phenomena

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review